The USPTO Guidance in response to Myriad runs counter to Supreme Court precedent and the TRIPS Agreement

By Moore, C. G., McBee, S., Flasche, W.

In response to the United States Supreme Court’s decisions in Prometheus and Myriad, the United States Patent and Trademark Office (USPTO) recently issued a Guidance for its patent examiners to determine whether claims directed to ‘laws of nature, natural phenomena, and natural proteins’ (eg natural products) are eligible for patent …read more

Source:: Journal of Intellectual Property Law & Practice